|
|
||||||||
Ann Thorac Surg 2007;83:725-726
© 2007 The Society of Thoracic Surgeons
Division of Cardiac Surgery, The Johns Hopkins Hospital, 600 North Wolfe St, Blalock 618, Baltimore, MD 21287
(Email: wbaumgar{at}csurg.jhmi.jhu.edu).
We would like to thank Drs Veinot and Ruel [1] for bringing up the issue of valproic acid as a cause of increased surgical bleeding. We are aware of this potential complication and appreciate their comments.
In our canine model, we did not see any significant bleeding [2]. However, clearly when we develop a safety trial for this drug and cardiopulmonary bypass, we will list this as one of the potential complicating factors in our informed consent. We also plan to ask our hematology colleagues as to whether there is a better hematology screening method when this drug is given immediately prior to operation. As the authors point out, it is unclear whether this potential bleeding complication is dose related or if it is idiosyncratic.
Once again we appreciate the authors comments.
| References |
|---|
|
|
|---|
Related Article
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |